Polio Eradication: Endgame Challenges, Lessons and Legacy
Sir Liam Donaldson, Chair, Independent Monitoring Board, Global Polio Eradication Initiative
Anil Dutta, Vice President Clinical R&D and Medical Affairs, GlaxoSmithKline
John Edmunds, Professor, London School of Hygiene and Tropical Medicine
Kate Kelland, Health and Science Correspondent, Reuters
Jason Lane, Senior Human Development Adviser, UK Department for International Development
Carole Lanteri, Ambassador and Permanent Representative, Permanent Mission of the Principality of Monaco to the UN Office et al.
David Salisbury, Associate Fellow, Chatham House Centre on Global Health Security
Emmanuel Vidor, Associate Vice President, Head of Global Medical Affairs, Sanofi Pasteur
Michel Zaffran, Director, Global Polio Eradication Initiative
Elizabeth Miller, Professor, Immunisation Hepatitis and Blood Safety Department, Public Health England
Jeremy Laurance, Health Editor, the Independent (1997-2013)
Many of the challenges we face in global health are governance not disease challenges. In the rapidly changing global health environment, we need to learn how to build on the experiences gained in different areas of work and to make sure that they feed into the demanding implementation of the Sustainable Development Goals (SDGs). There has been much debate as to the value of vertical vs. horizontal programming in global health, and looking back at significant MDG achievements in health, we now have the opportunity to assess impact and outcomes.
At this meeting, leaders in global health will discuss the challenges of the polio endgame and the multi-faceted legacy of polio eradication.
This event is jointly organized by the Global Health Programme at the Graduate Institute and the Chatham House Centre on Global Health Security.